Precision Biosciences (DTIL) Non-cash Items (2018 - 2025)
Precision Biosciences (DTIL) reported Non-cash Items of $9.7 million for Q1 2025, down 28.68% year-over-year from $13.6 million in Q1 2024, and up 3801.58% quarter-over-quarter from $248617.0 in Q4 2024.
Precision Biosciences (DTIL) Non-cash Items (2018 - 2025) Analysis & Trends
Precision Biosciences (DTIL) has 8 years of Non-cash Items data on file, last reported at $9.7 million in Q1 2025.
- Non-cash Items for Q1 2025 came in at $9.7 million, down 28.68% year-over-year; the trailing twelve-month figure through Mar 2025 was $9.7 million (down 28.68% YoY), and the FY2024 annual result was $248617.0, down 98.51% from the prior year.
- Non-cash Items grew to $9.7 million in Q1 2025 per DTIL's latest filing, from $248617.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $44.3 million in Q2 2021 and troughed at $176113.0 in Q4 2022.
- A 5-year average of $21.3 million and a median of $20.2 million in 2023 frame the typical range for Non-cash Items.
- On a YoY basis, Non-cash Items climbed as much as 59.41% in 2022 and fell as far as 96.36% in 2022.
- A 5-year view of Non-cash Items shows it stood at $4.8 million in 2021, then plunged by 96.36% to $176113.0 in 2022, then grew by 26.63% to $223019.0 in 2023, then gained by 11.48% to $248617.0 in 2024, then surged by 3801.58% to $9.7 million in 2025.
- Business Quant data shows DTIL's Non-cash Items at $9.7 million in Q1 2025, $248617.0 in Q4 2024, and $16.7 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 9.70 Mn |
| Mar 31, 2025 | 9.70 Mn |
| Dec 31, 2024 | 248,617.00 |
| Dec 31, 2024 | 248,617.00 |
| Sep 30, 2024 | 16.70 Mn |
| Sep 30, 2024 | 16.70 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 13.60 Mn |
| Mar 31, 2024 | 13.60 Mn |
| Dec 31, 2023 | 223,019.00 |
| Dec 31, 2023 | 223,019.00 |
| Sep 30, 2023 | 20.20 Mn |
| Sep 30, 2023 | 20.20 Mn |
| Jun 30, 2023 | 25.50 Mn |
| Jun 30, 2023 | 25.50 Mn |
| Mar 31, 2023 | 29.60 Mn |
| Mar 31, 2023 | 29.60 Mn |
| Dec 31, 2022 | 176,113.00 |
| Dec 31, 2022 | 176,113.00 |